Review
doi: 10.1016/j.ncl.2011.05.004. Epub 2011 Jun 24.Neurologic manifestations of chronic methamphetamine abuse
Affiliations
- PMID:21803215
- PMCID: PMC3148451
- DOI: 10.1016/j.ncl.2011.05.004
Item in Clipboard
Review
Neurologic manifestations of chronic methamphetamine abuse
Daniel E Rusyniak. Neurol Clin.2011 Aug.
Display options
Format
Display options
Format
Abstract
Methamphetamine abuse has reached epidemic proportions in the United States. The repetitive use of methamphetamine causes massive and sustained elevations in central monoamines. These elevations, particularly in dopamine, can cause changes in the function of the central nervous system that can manifest as a variety of neurologic disorders. This article focuses on these disorders, such as neurocognitive disorders and mental illness, including drug-induced psychosis; motor disorders, including the possible risk of Parkinson's disease, the development of choreoathetoid movements, and punding; and changes in the physical appearance of the methamphetamine users, including dental caries.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
- Neurologic manifestations of chronic methamphetamine abuse.Rusyniak DE.Rusyniak DE.Psychiatr Clin North Am. 2013 Jun;36(2):261-75. doi: 10.1016/j.psc.2013.02.005. Epub 2013 Apr 11.Psychiatr Clin North Am. 2013.PMID:23688691Free PMC article.Review.
- Methamphetamine abuse: medical and dental considerations.Smart RJ, Rosenberg M.Smart RJ, et al.J Mass Dent Soc. 2005 Summer;54(2):44-6, 48-9.J Mass Dent Soc. 2005.PMID:16149403
- Will the methamphetamine problem go away?Rawson RA, Anglin MD, Ling W.Rawson RA, et al.J Addict Dis. 2002;21(1):5-19. doi: 10.1300/j069v21n01_02.J Addict Dis. 2002.PMID:11831500Review.
- [Amphetamine-induced psychosis or schizophrenia?].Rognli EB, Medhus SE, Bramness JG.Rognli EB, et al.Tidsskr Nor Laegeforen. 2015 Feb 10;135(3):249-51. doi: 10.4045/tidsskr.14.1365. eCollection 2015 Feb 10.Tidsskr Nor Laegeforen. 2015.PMID:25668544Norwegian.No abstract available.
- [Spontaneous recrudescence of psychotic diseases caused by methamphetamine (a stimulant): the stress type and the role of noradrenaline and dopamine systems].Aburai K, Ikemoto U, Goto K.Aburai K, et al.Nihon Shinkei Seishin Yakurigaku Zasshi. 2004 Oct;24(5):319-20.Nihon Shinkei Seishin Yakurigaku Zasshi. 2004.PMID:15658512Japanese.No abstract available.
Cited by
- Frequency of reported methamphetamine use linked to prevalence of clinical conditions, sexual risk behaviors, and social adversity in diverse men who have sex with men in Los Angeles.Shoptaw S, Li MJ, Javanbakht M, Ragsdale A, Goodman-Meza D, Gorbach PM.Shoptaw S, et al.Drug Alcohol Depend. 2022 Mar 1;232:109320. doi: 10.1016/j.drugalcdep.2022.109320. Epub 2022 Jan 19.Drug Alcohol Depend. 2022.PMID:35093681Free PMC article.
- Substance of abuse and movement disorders: complex interactions and comorbidities.Deik A, Saunders-Pullman R, Luciano MS.Deik A, et al.Curr Drug Abuse Rev. 2012 Sep;5(3):243-53. doi: 10.2174/1874473711205030243.Curr Drug Abuse Rev. 2012.PMID:23030352Free PMC article.Review.
- Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis.Kim R, Healey KL, Sepulveda-Orengo MT, Reissner KJ.Kim R, et al.Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt A):126-146. doi: 10.1016/j.pnpbp.2017.10.002. Epub 2017 Oct 6.Prog Neuropsychopharmacol Biol Psychiatry. 2018.PMID:28989099Free PMC article.Review.
- Crystal methamphetamine and its effects on mental and oral health: A narrative review.Alqarni H, Aldghim A, Alkahtani R, Alshahrani N, Altoman MS, Alfaifi MA, Helmi M, Alzaid AA.Alqarni H, et al.Saudi Dent J. 2024 May;36(5):665-673. doi: 10.1016/j.sdentj.2024.02.011. Epub 2024 Feb 25.Saudi Dent J. 2024.PMID:38766295Free PMC article.Review.
- Human Immunodeficiency Virus Type 1 and Methamphetamine-Mediated Mitochondrial Damage and Neuronal Degeneration in Human Neurons.Teodorof-Diedrich C, Spector SA.Teodorof-Diedrich C, et al.J Virol. 2020 Sep 29;94(20):e00924-20. doi: 10.1128/JVI.00924-20. Print 2020 Sep 29.J Virol. 2020.PMID:32796068Free PMC article.
References
- Streatfeild D. Cocaine: An Unauthorized Biography. New York: Picador; 2001.
- Nagai T, Kamiyama S. Forensic toxicologic analysis of methamphetamine and amphetamine optical isomers by high performance liquid chromatography. Int J Legal Med. 1988;101:151–9. - PubMed
- Nagai H. Studies on the components of Ephedraceae in herb medicine. Yahugaku Zasshi. 1893;139:901–33.
- Miller MA. History and Epidemiology of Amphetamine Abuse in the United States. In: Klee H, editor. Amphetamine Misuse: International Perspectives on Current Trends. Reading, UK: Harwood Academic Publishers; 1997. pp. 113–33.
- Anglin MD, Burke C, Perrochet B, et al. History of the methamphetamine problem. J Psychoactive Drugs. 2000;32:137–41. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical